Taking A Dive Into Bed Bath & Beyond

| About: Bed Bath (BBBY)

It's September and college students have packed up and moved into their new dorms across the county. For Bed Bath & Beyond (NASDAQ:BBBY), this is the most wonderful time of the year. With great name recognition and strong market performance, it's easy to see why Valuentum believes Bed Bath & Beyond is trading so close to its fair value.

At Valuentum, we think a comprehensive analysis of a firm's discounted cash-flow valuation, relative valuation versus industry peers, as well as an assessment of technical and momentum indicators is the best way to identify the most attractive stocks at the best time to buy. This process culminates in what we call our Valuentum Buying Index, which ranks stocks on a scale from 1 to 10, with 10 being the best.

If a firm is undervalued both on a discounted cash-flow and on a relative valuation basis and is showing improvement in technical and momentum indicators, it scores high on our scale. As you can see in our analysis, Bed Bath & Beyond only scores a 6 on our scale, making it fairly valued but not in line with our ideal 9 or 10 scores for stocks that we'd consider adding to our Best Ideas portfolio.

Click to enlarge

Our Report on Bed Bath & Beyond

Valuentum ReportClick to enlarge

Investment Considerations

Investment ConsiderationsClick to enlarge

Investment Highlights

  • Bed Bath & Beyond's business quality (an evaluation of our ValueCreationTM and ValueRiskTM ratings) ranks among the best of the firms in our coverage universe. The firm has been generating economic value for shareholders with relatively stable operating results for the past few years, a combination we view very positively.
  • Bed Bath & Beyond offers domestic merchandise and home furnishings. Though the firm's goal to offer quality merchandise at everyday low prices is admirable, such a strategy is not new or unique.
  • Bed Bath & Beyond has an excellent combination of strong free cash flow generation and low financial leverage. We expect the firm's free cash flow margin to average about 9.1% in coming years, and the firm had no debt as of last quarter.
  • Although we think there may be a better time to dabble in the firm's shares based on our DCF process, the firm's stock has outperformed the market benchmark during the past quarter, indicating increased investor interest in the company.
  • Bed Bath & Beyond has grown from just a few dozen stores in fiscal 1992 to over 1,400 today. We expect the company's expansion plans to continue.

Business Quality

Business QualityClick to enlarge

Economic Profit Analysis

The best measure of a firm's ability to create value for shareholders is expressed by comparing its return on invested capital (ROIC) with its weighted average cost of capital (OTC:WACC). The gap or difference between ROIC and WACC is called the firm's economic profit spread. Bed Bath & Beyond's 3-year historical return on invested capital (without goodwill) is 48.5%, which is above the estimate of its cost of capital of 10.8%. As such, we assign the firm a ValueCreationTM rating of EXCELLENT. In the chart below, we show the probable path of ROIC in the years ahead based on the estimated volatility of key drivers behind the measure. The solid grey line reflects the most likely outcome, in our opinion, and represents the scenario that results in our fair value estimate.

ROICClick to enlarge

WACCClick to enlarge

Valuation Analysis

We think Bed, Bath & Beyond's shares are worth $73 each, which represents a price-to-earnings (P/E) ratio of about 14.6 times last year's earnings and an implied EV/EBITDA multiple of about 8.5 times last year's EBITDA. Our model reflects a compound annual revenue growth rate of 5% during the next five years, a pace that is lower than the firm's 3-year historical compound annual growth rate of 7.6%. Our model reflects a 5-year projected average operating margin of 14.5%, which is below Bed Bath & Beyond's trailing 3-year average. Beyond year 5, we assume free cash flow will grow at an annual rate of 0.9% for the next 15 years and 3% in perpetuity. For Bed Bath & Beyond, we use a 10.8% weighted average cost of capital to discount future free cash flows.

AssumptionsClick to enlarge

BreakdownClick to enlarge

MetricsClick to enlarge

Margin of Safety Analysis

Our discounted cash flow process values each firm on the basis of the present value of all future free cash flows. Although we estimate the firm's fair value at about $73 per share, every company has a range of probable fair values that's created by the uncertainty of key valuation drivers (like future revenue or earnings, for example). After all, if the future was known with certainty, we wouldn't see much volatility in the markets as stocks would trade precisely at their known fair values. Our ValueRiskTM rating sets the margin of safety or the fair value range we assign to each stock. In the graph below, we show this probable range of fair values for Bed Bath & Beyond. We think the firm is attractive below $58 per share (the green line), but quite expensive above $88 per share (the red line). The prices that fall along the yellow line, which includes our fair value estimate, represent a reasonable valuation for the firm, in our opinion.

Potential OutcomesClick to enlarge

Future Path of Fair Value

We estimate Bed Bath & Beyond's fair value at this point in time to be about $73 per share. As time passes, however, companies generate cash flow and pay out cash to shareholders in the form of dividends. The chart to the right compares the firm's current share price with the path of Bed Bath & Beyond's expected equity value per share over the next three years, assuming our long-term projections prove accurate. The range between the resulting downside fair value and upside fair value in Year 3 represents our best estimate of the value of the firm's shares three years hence. This range of potential outcomes is also subject to change over time, should our views on the firm's future cash flow potential change. The expected fair value of $99 per share in Year 3 represents our existing fair value per share of $73 increased at an annual rate of the firm's cost of equity less its dividend yield. The upside and downside ranges are derived in the same way, but from the upper and lower bounds of our fair value estimate range.

Path of Fair ValueClick to enlarge

Pro Forma Financial Statements

ISClick to enlarge

BSClick to enlarge

SCFClick to enlarge

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.